Form 4 Tracker
Christopher Gibson

Director · 14 filings · Latest: Jun 5, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Gibson Christopher—Jul 9, 2026
Proposed Sale
$3.80286,000$1.1M—
RXRX
Gibson Christopher—Jul 8, 2026
Proposed Sale
$3.69200,000$737.7K—
RXRX
Gibson Christopher—Jul 7, 2026
Proposed Sale
$3.95250,000$987.5K—
RXRX
Gibson Christopher—Jul 6, 2026
Proposed Sale
$3.78100,000$378.0K—
RXRX
Gibson Christopher—Jul 2, 2026
Proposed Sale
$3.75100,000$374.5K—
RXRX
Gibson Christopher—Jul 1, 2026
Proposed Sale
$3.67100,000$366.6K—
RXRX
Gibson Christopher—Jun 18, 2026
Proposed Sale
$3.20300,440$962.3K—
RXRX
Gibson Christopher—Jun 18, 2026
Proposed Sale
$3.1840,000$127.2K—
RXRX
Christopher GibsonDirectorJun 5, 2026
Sale
$3.6240,000$144.8K883,735
RXRX
Gibson Christopher—Jun 5, 2026
Proposed Sale
$3.6240,000$144.8K—
RXRX
Christopher GibsonDirectorMay 22, 2026
Sale
$3.0840,000$123.2K883,735
RXRX
Gibson Christopher—May 22, 2026
Proposed Sale
$3.0840,000$123.2K—
RXRX
Christopher GibsonDirectorMay 7, 2026
Sale
$3.3740,000$134.8K926,556
RXRX
Gibson Christopher—May 7, 2026
Proposed Sale
$3.3740,000$134.8K—
RXRX
Christopher GibsonDirectorApr 22, 2026
Sale
$3.6140,000$144.4K906,556
RXRX
Gibson Christopher—Apr 22, 2026
Proposed Sale
$3.6140,000$144.4K—
RXRX
Christopher GibsonDirectorApr 7, 2026
Sale
$3.1040,000$124.0K906,556
RXRX
Gibson Christopher—Apr 7, 2026
Proposed Sale
$3.1040,000$124.0K—
RXRX
Christopher GibsonDirectorMar 23, 2026
Sale
$3.2540,000$130.0K906,556
RXRX
Gibson Christopher—Mar 23, 2026
Proposed Sale
$3.2540,000$130.0K—